RU2007123595A - Диагностический способ для прогнозирования потери трансплантированного органа - Google Patents
Диагностический способ для прогнозирования потери трансплантированного органа Download PDFInfo
- Publication number
- RU2007123595A RU2007123595A RU2007123595/15A RU2007123595A RU2007123595A RU 2007123595 A RU2007123595 A RU 2007123595A RU 2007123595/15 A RU2007123595/15 A RU 2007123595/15A RU 2007123595 A RU2007123595 A RU 2007123595A RU 2007123595 A RU2007123595 A RU 2007123595A
- Authority
- RU
- Russia
- Prior art keywords
- loss
- diagnostic method
- transplanted
- predicting
- forecasting
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- External Artificial Organs (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Compounds Of Unknown Constitution (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
1. Диагностический способ для предвидения потери трансплантированного органа путем измерения повышенных предтранспантационных уровней CXCL9 (MIG) в сыворотке.2. Способ по п.1 для предвидения острого отторжения трансплантированного органа.3. Способ по п.1 для предвидения хронического отторжения трансплантированного органа.4. Способ по любому из пп.1-3, в котором трансплантированными органами являются почка, сердце, печень, костный мозг, легкое, поджелудочная железа или панкреатические островки, кишечник.5. Способ по п.4, в котором сывороточный уровень измеряют твердофазным иммуноферментным анализом (ELISA).
Claims (5)
1. Диагностический способ для предвидения потери трансплантированного органа путем измерения повышенных предтранспантационных уровней CXCL9 (MIG) в сыворотке.
2. Способ по п.1 для предвидения острого отторжения трансплантированного органа.
3. Способ по п.1 для предвидения хронического отторжения трансплантированного органа.
4. Способ по любому из пп.1-3, в котором трансплантированными органами являются почка, сердце, печень, костный мозг, легкое, поджелудочная железа или панкреатические островки, кишечник.
5. Способ по п.4, в котором сывороточный уровень измеряют твердофазным иммуноферментным анализом (ELISA).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITFI2004A000243 | 2004-11-25 | ||
| IT000243A ITFI20040243A1 (it) | 2004-11-25 | 2004-11-25 | Metodo diagnostico per la previsione di rigetto di organo trapiantato |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2007123595A true RU2007123595A (ru) | 2008-12-27 |
Family
ID=35929598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007123595/15A RU2007123595A (ru) | 2004-11-25 | 2005-11-24 | Диагностический способ для прогнозирования потери трансплантированного органа |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20080009023A1 (ru) |
| EP (1) | EP1820025B1 (ru) |
| JP (1) | JP2008522141A (ru) |
| AT (1) | ATE412909T1 (ru) |
| AU (1) | AU2005308838A1 (ru) |
| CA (1) | CA2589251A1 (ru) |
| DE (1) | DE602005010743D1 (ru) |
| ES (1) | ES2317340T3 (ru) |
| IT (1) | ITFI20040243A1 (ru) |
| RU (1) | RU2007123595A (ru) |
| WO (1) | WO2006056583A1 (ru) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7026121B1 (en) * | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US7244555B2 (en) * | 2002-05-14 | 2007-07-17 | Renovak Inc | Systems and methods for identifying organ transplant risk |
| CA2487732C (en) * | 2002-05-28 | 2013-10-15 | Bette Pollard | Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders |
| DK1515990T3 (da) * | 2002-06-12 | 2007-06-11 | Applied Research Systems | Antagonister af CXCR3-bindende CXC chemokiner |
| AU2003302340B8 (en) * | 2002-12-24 | 2008-09-11 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| ITFI20030058A1 (it) * | 2003-03-06 | 2004-09-07 | Univ Firenze | Formulazioni farmaceutiche contenenti tiazolidinedioni |
-
2004
- 2004-11-25 IT IT000243A patent/ITFI20040243A1/it unknown
-
2005
- 2005-11-24 CA CA002589251A patent/CA2589251A1/en not_active Abandoned
- 2005-11-24 EP EP05823506A patent/EP1820025B1/en active Active
- 2005-11-24 AU AU2005308838A patent/AU2005308838A1/en not_active Abandoned
- 2005-11-24 ES ES05823506T patent/ES2317340T3/es active Active
- 2005-11-24 WO PCT/EP2005/056186 patent/WO2006056583A1/en active Application Filing
- 2005-11-24 RU RU2007123595/15A patent/RU2007123595A/ru not_active Application Discontinuation
- 2005-11-24 JP JP2007541985A patent/JP2008522141A/ja active Pending
- 2005-11-24 AT AT05823506T patent/ATE412909T1/de not_active IP Right Cessation
- 2005-11-24 US US11/791,350 patent/US20080009023A1/en not_active Abandoned
- 2005-11-24 DE DE602005010743T patent/DE602005010743D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ATE412909T1 (de) | 2008-11-15 |
| CA2589251A1 (en) | 2006-06-01 |
| AU2005308838A1 (en) | 2006-06-01 |
| ITFI20040243A1 (it) | 2005-02-25 |
| EP1820025A1 (en) | 2007-08-22 |
| JP2008522141A (ja) | 2008-06-26 |
| DE602005010743D1 (de) | 2008-12-11 |
| WO2006056583A1 (en) | 2006-06-01 |
| EP1820025B1 (en) | 2008-10-29 |
| US20080009023A1 (en) | 2008-01-10 |
| ES2317340T3 (es) | 2009-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Meijers et al. | The uremic retention solute p-cresyl sulfate and markers of endothelial damage | |
| ATE533859T1 (de) | MARKER FÜR NIERENTRANSPLANTATABSTOßUNG UND NIERENSCHÄDEN | |
| Balaoing et al. | Age-related changes in aortic valve hemostatic protein regulation | |
| DE602005026273D1 (de) | Vorrichtungen und verfahren für abnahme, lagerung und transport von biologischen proben | |
| CA2601623C (en) | Methods and compositions for evaluating graft survival in a solid organ transplant recipient | |
| WO2008063479A3 (en) | Pancreatic cancer biomarkers | |
| ATE535612T1 (de) | Toxizitätsscreeningverfahren | |
| ATE412905T1 (de) | Diagnoseverfahren für lebersteatose unter verwendung biochemischer marker | |
| RU2009139295A (ru) | Биомаркеры и биомаркерные признаки почечной сохранности, обладающие предсказательной силой, для использования в мониторинге состояния почек | |
| Nolasco et al. | Human complement factor H is a reductase for large soluble von Willebrand factor multimers—brief report | |
| RU2013138721A (ru) | Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови | |
| Dam et al. | Inhibition of cystathionine gamma-lyase and the biosynthesis of endogenous hydrogen sulphide ameliorates gentamicin-induced nephrotoxicity | |
| ATE463557T1 (de) | Verfahren zur anreicherung fötaler zellen | |
| de Vries et al. | Cell release during perfusion reflects cold ischemic injury in rat livers | |
| RU2007123595A (ru) | Диагностический способ для прогнозирования потери трансплантированного органа | |
| Sevinc et al. | Ex vivo perfusion characteristics of donation after cardiac death kidneys predict long-term graft survival | |
| ATE456797T1 (de) | Verwendung von nogo-c bei der beurteilung von herzversagen | |
| ATE534907T1 (de) | Verfahren für den nachweis von l523s-expression in biologischen proben | |
| ATE298088T1 (de) | Verfahren zur vorhersage eines transplantatabstossungsrisikos und immunologischer testkit | |
| Shyu et al. | Kinetics and functional assay of liver repopulation after human cord blood transplantation | |
| Juriasingani | 21 C is the emerging ideal temperature for kidney preservation in the presence of hydrogen sulfide | |
| MX2021013666A (es) | Métodos y composiciones para revertir la acumulacion de plaquetas. | |
| Grande et al. | Preoperative evaluation and arrangements for multiorgan donation: general principles and contraindications | |
| BRPI0406242A (pt) | processos de combinação cruzada especìfica ao doador | |
| Hussin | Prof. Dr. Amin Mohamed Roshdy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20110319 |